FDA approves first once-daily oral cholesterol pill: How it works, who can take it, and how it compares with statins and injections

The FDA has approved Lipfendra, a new daily oral medication for high cholesterol. This drug belongs to a newer class of ...
The Print on MSN

How 1st FDA approved once-a-day pill to lower ‘bad’ cholesterol could shift treatment from statins

FDA has approved Lipfendra, developed by American pharmaceutical company Merck, for adults with high LDL cholesterol. It ...

A Novel Pill For Cholesterol: FDA Approves Lipfendra

A significant breakthrough in heart disease prevention arrived on July 16, 2026, with the FDA approval of Lipfendra ...
ABC7 KABC

FDA approves 1st-of-its-kind pill to reduce cholesterol

The FDA has approved a first-of-its-kind pill that can lower "bad" LDL cholesterol with a daily pill instead of a shot.

Merck gets US FDA nod for first-in-its-class oral cholesterol drug

The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 ...

What do we know about the new cholesterol pill, Lipfendra? Merck's new once-a-day drug gets FDA nod

The FDA has approved Merck's once-daily cholesterol pill Lipfendra (enlicitide), marking the first oral PCSK9 inhibitor.

Type 1 Diabetes: Can Insulin Ever Be Replaced By A Pill? Doctors Answer

Dr Anoop Misra and Dr Ambrish Mithal explain why insulin injections can't be replaced by a pill. Here is what happened to a ...

Game-changing cholesterol pill wins FDA approval after cutting LDL nearly 60%

Lipfendra, the first once-daily oral PCSK9 inhibitor, was shown to reduce LDL cholesterol by roughly 56% to 60% when combined ...

Cholesterol Pills That Work Better Than Statins Get Approval: Lipfendra Explained

High cholesterol is one of the major risk factors for heart disease and stroke. While statins have been the most common ...
India Today on MSN

FDA clears first daily pill that could change bad cholesterol treatment

The USFDA has approved Lipfendra, the first oral PCSK9 inhibitor, for lowering LDL cholesterol. The once-daily pill could improve long-term adherence, though Indian access will depend on approval and ...

Merck gets FDA approval for first oral PCSK9 cholesterol pill

Lipfendra, a once-daily pill, reduced LDL cholesterol by up to 59% in late-stage trials, rivaling existing injectable ...
ConsumerAffairs

First cholesterol pill of its kind wins FDA approval

The FDA has approved Lipfendra (enlicitide), the first once-daily oral PCSK9 inhibitor for adults with high cholesterol.The ...